
  
    
      
        Introduction_NNP
        As_IN initially_RB described_VBN by_IN Poiseuille_NNP 's_POS law_NN ,_, resistance_NN
        to_TO flow_VB is_VBZ that_DT resistance_NN provided_VBN by_IN a_DT vessel_NN or_CC
        circulatory_NN bed_NN which_WDT permits_VBZ a_DT given_VBN pressure_NN differential_NN
        to_TO produce_VB a_DT unit_NN flow_NN ._. Transcribed_NNP to_TO human_JJ hemodynamics_NNS ,_,
        systemic_JJ vascular_NN resistance_NN (_( SVR_NNP )_) can_MD be_VB measured_VBN from_IN the_DT
        differential_NN pressure_NN between_IN the_DT mean_JJ arterial_NN pressure_NN
        (_( MAP_NNP )_) and_CC the_DT central_JJ venous_JJ pressure_NN (_( CVP_NNP )_) divided_VBN by_IN the_DT
        flow_NN ,_, ie_NN cardiac_JJ output_NN (_( CO_NNP )_) ._. Although_IN many_JJ clinical_JJ
        conditions_NNS can_MD cause_VB a_DT low_JJ SVR_NNP ,_, septic_JJ shock_NN remains_VBZ the_DT
        most_RBS common_JJ cause_NN and_CC usually_RB results_NNS in_IN a_DT severe_JJ decrease_NN
        in_IN SVR_NNP ._. In_IN more_JJR than_IN 90_CD %_NN of_IN patients_NNS with_IN septic_JJ shock_NN who_WP
        are_VBP aggressively_RB volume_NN loaded_VBD ,_, the_DT CO_NNP is_VBZ initially_RB normal_JJ
        or_CC elevated_VBD ._. Therefore_RB ,_, hypotension_NN results_NNS from_IN reduced_VBN
        vascular_NN resistance_NN with_IN normal_JJ or_CC elevated_VBD CO_NNP ._. This_DT form_NN
        of_IN shock_NN results_NNS from_IN maldistribution_NN of_IN blood_NN flow_NN to_TO
        tissues_NNS ,_, usually_RB from_IN acute_JJ vasodilatation_NN without_IN
        concomitant_NN expansion_NN of_IN the_DT intravascular_NN volume_NN ._. While_IN
        distributive_JJ shock_NN can_MD also_RB be_VB caused_VBN by_IN anaphylaxis_NNS ,_, drug_NN
        ingestion_NN ,_, neurogenic_JJ injury_NN ,_, and_CC adrenal_NN insufficiency_NN ,_,
        these_DT conditions_NNS are_VBP seen_VBN with_IN less_JJR frequency_NN in_IN the_DT
        intensive_JJ care_NN unit_NN ._. Therefore_RB ,_, a_DT hemodynamic_JJ state_NN with_IN
        low_JJ SVR_NNP is_VBZ often_RB considered_VBN synonymous_JJ of_IN sepsis_NN ,_, and_CC other_JJ
        conditions_NNS associated_VBN with_IN a_DT low_JJ SVR_NNP may_MD not_RB be_VB
        considered_VBN ._.
        There_EX are_VBP minimal_JJ data_NNS in_IN the_DT medical_JJ literature_NN
        assessing_VBG the_DT frequency_NN or_CC outcome_NN of_IN patients_NNS with_IN
        distributive_JJ shock_NN that_WDT is_VBZ unrelated_JJ to_TO sepsis_NN or_CC the_DT
        sepsis_NN syndrome_NN ._. Since_IN we_PRP could_MD find_VB no_DT prior_JJ studies_NNS in_IN
        the_DT literature_NN assessing_VBG the_DT etiology_NN and_CC outcome_NN of_IN
        hypotensive_JJ patients_NNS with_IN a_DT low_JJ SVR_NNP ,_, we_PRP reviewed_VBD our_PRP$
        experience_NN with_IN patients_NNS undergoing_VBG hemodynamic_JJ monitoring_NN
        in_IN the_DT medical_JJ intensive_JJ care_NN unit_NN of_IN a_DT large_JJ university_NN
        hospital_NN ._. The_DT purpose_NN of_IN this_DT study_NN was_VBD to_TO determine_VB the_DT
        different_JJ causes_NNS of_IN low_JJ SVR_NNP ,_, identify_VB prognostic_JJ factors_NNS ,_,
        and_CC analyze_VB the_DT mortality_NN of_IN these_DT various_JJ groups_NNS of_IN
        patients_NNS ._.
      
      
        Methods_NNP
        After_IN approval_NN by_IN the_DT Institutional_NNP Review_NNP Board_NNP of_IN the_DT
        University_NNP of_IN Texas_NNP Health_NNP Science_NNP Center_NNP at_IN San_NNP Antonio_NNP ,_,
        medical_JJ records_NNS of_IN all_DT patients_NNS admitted_VBN to_TO the_DT medical_JJ
        intensive_JJ care_NN unit_NN of_IN the_DT University_NNP Hospital_NNP between_IN
        1990_CD -_: 1995_CD were_VBD reviewed_VBN ._. All_DT the_DT charts_NNS of_IN patients_NNS
        undergoing_VBG pulmonary_JJ artery_NN catheterization_NN were_VBD
        identified_VBN ._. Patients_NNS with_IN a_DT recorded_VBN SVR_NNP less_JJR than_IN 800_CD
        dynes_NNS ×_NN s_VBZ /_NN cm_NN 5_CD were_VBD analyzed_VBN ._. The_DT main_JJ indication_NN for_IN
        pulmonary_JJ artery_NN catheterization_NN in_IN patients_NNS in_IN this_DT study_NN
        was_VBD unexplained_JJ hypotension_NN after_IN volume_NN challenge_NN ._. Any_DT
        patient_NN with_IN an_DT unclear_JJ etiology_NN for_IN hypotension_NN or_CC any_DT
        patient_NN requiring_VBG more_JJR than_IN 10_CD μ_NN g_SYM /_NN kg_NN /_NN min_NN dopamine_NN
        underwent_VBD pulmonary_JJ artery_NN catheterization_NN and_CC was_VBD reviewed_VBN
        for_IN this_DT study_NN ._. Anxiolytics_NNP ,_, sedatives_NNS ,_, and_CC neuromuscular_NN
        blocking_VBG agents_NNS are_VBP administered_VBN by_IN protocol_NN and_CC have_VBP
        minimal_JJ or_CC no_DT direct_JJ effects_NNS on_IN hemodynamics_NNS or_CC histamine_NN
        release_NN ._. Cultures_NNP of_IN blood_NN and_CC urine_NN were_VBD obtained_VBN on_IN all_DT
        patients_NNS ;_: cultures_NNS of_IN sputum_NN ,_, pleural_NN fluid_JJ ,_, ascitic_JJ fluid_NN ,_,
        and_CC cerebrospinal_NN fluid_NN were_VBD obtained_VBN as_RB clinically_RB
        indicated_VBD ._. Toxicological_NNP screening_NN of_IN blood_NN and_CC urine_NN for_IN
        drugs_NNS was_VBD performed_VBN on_IN admission_NN if_IN the_DT etiology_NN of_IN
        hypotension_NN was_VBD in_IN question_NN ._. Serum_NNP cortisol_NN level_NN
        determination_NN was_VBD performed_VBN on_IN all_DT patients_NNS receiving_VBG
        exogenous_JJ corticosteroids_NNS or_CC in_IN patients_NNS with_IN known_VBN risk_NN
        factors_NNS for_IN adrenal_NN insufficiency_NN ._. Hematologic_NNP and_CC blood_NN
        chemistry_NN determinations_NNS ,_, arterial_NN blood_NN gases_NNS ,_, routine_JJ
        urinalysis_NNS ,_, and_CC serial_NN electrocardiograms_NNS were_VBD obtained_VBN on_IN
        all_DT patients_NNS ._.
        Mean_VB systemic_JJ ,_, right_JJ atrial_NN ,_, and_CC pulmonary_JJ artery_NN
        pressures_NNS and_CC thermodilution_NN cardiac_JJ outputs_NNS were_VBD measured_VBN
        every_DT 4_CD h_NN in_IN all_DT patients_NNS ._. Derived_NNP hemodynamic_JJ variables_NNS
        were_VBD calculated_VBN as_IN follows_VBZ :_: cardiac_JJ index_NN (_( CI_NNP ;_: l_NN /_NN min_NN /_NN m_NN 2_LS )_) =_SYM
        CO_NNP /_NN body_NN surface_NN area_NN ;_: SVR_NNP (_( dynes_NNS ×_NN s_VBZ /_NN cm_NN 5_LS )_) =_SYM (_( 80_CD ×_NN MAP_NNP )_) /_NN CO_NNP ;_:
        and_CC systemic_JJ vascular_NN resistance_NN index_NN (_( SVRI_NNP )_) =_SYM SVR_NNP /_NN body_NN
        surface_NN area_NN ._. Patients_NNS received_VBD vasopressors_NNS to_TO maintain_VB
        MAP_NNP above_IN 70_CD mmHg_NN ._. The_DT set_NN of_IN hemodynamic_JJ data_NNS with_IN the_DT
        lowest_JJS SVR_NNP was_VBD selected_VBN for_IN each_DT patient_NN ._.
        All_DT historical_JJ ,_, clinical_JJ ,_, laboratory_NN ,_, microbiologic_JJ ,_, and_CC
        hemodynamic_JJ data_NNS were_VBD studied_VBN ._. Patients_NNS were_VBD divided_VBN into_IN
        four_CD groups_NNS based_VBN on_IN the_DT following_JJ parameters_NNS :_: (_( 1_LS )_) positive_JJ
        blood_NN culture_NN ;_: (_( 2_LS )_) temperature_NN ≥_NN 38_CD ._. 1_LS °_NN C_NNP or_CC ≤_NN 36_CD °_NN C_NNP ;_: (_( 3_LS )_)
        white_JJ blood_NN counts_VBZ (_( WBCs_NNP )_) ≥_NN 12000_CD /_NN mm_NN 3_CD or_CC ≤_NN 4000_CD /_NN mm_NN 3_CD ;_: and_CC
        (_( 4_LS )_) obvious_JJ source_NN of_IN infection_NN ._. Group_NNP 1_CD (_( definite_JJ sepsis_NN )_)
        had_VBD positive_JJ blood_NN cultures_NNS and_CC two_CD or_CC more_JJR criteria_NNS ;_: Group_NNP
        2_CD (_( probable_JJ sepsis_NN )_) had_VBD an_DT obvious_JJ source_NN of_IN infection_NN and_CC
        two_CD or_CC more_RBR additional_JJ criteria_NNS ;_: Group_NNP 3_CD (_( possible_JJ sepsis_NN )_)
        had_VBD fever_NN and_CC leukocytosis_NNS or_CC leukopenia_NN with_IN no_DT obvious_JJ
        source_NN of_IN infection_NN nor_CC positive_JJ blood_NN culture_NN ;_: and_CC Group_NNP 4_CD
        (_( nonseptic_JJ )_) had_VBD none_NN of_IN the_DT criteria_NNS ._.
        The_DT clinical_JJ course_NN ,_, laboratory_NN findings_NNS ,_, hemodynamics_NNS ,_,
        and_CC intensive_JJ care_NN unit_NN mortality_NN were_VBD compared_VBN between_IN the_DT
        various_JJ groups_NNS ._. Data_NNP are_VBP expressed_VBN as_IN mean_NN ±_NN standard_JJ
        deviation_NN ._. Clinical_NNP and_CC hemodynamic_JJ variables_NNS were_VBD compared_VBN
        with_IN a_DT student_NN 's_POS 
        t_NN -_: test_NN and_CC by_IN analysis_NN of_IN variance_NN
        to_TO assess_VB statistical_JJ significance_NN between_IN groups_NNS ._. Logistic_NNP
        regression_NN analysis_NN was_VBD performed_VBN comparing_VBG SVR_NNP and_CC death_NN
        using_VBG a_DT univariant_NN analysis_NN ._.
        Mortality_NNP was_VBD assessed_VBN by_IN Mann-_NNP Whitney_NNP rank_NN sum_NN test_NN ._. A_DT 
        P_NN value_NN of_IN ≤_NN 0_CD ._. 05_CD was_VBD considered_VBN
        statistically_RB significant_JJ ._.
      
      
        Results_NNS
        Fifty-five_NNP patients_NNS were_VBD included_VBN in_IN the_DT study_NN (_( Table_NNP
        1_LS )_) ._. Group_NNP 1_CD contained_VBD 18_CD patients_NNS with_IN definite_JJ sepsis_NN ;_:
        Group_NNP 2_CD contained_VBD four_CD patients_NNS with_IN probable_JJ sepsis_NN ;_: Group_NNP
        3_CD contained_VBD 20_CD patients_NNS with_IN possible_JJ sepsis_NN ;_: and_CC Group_NNP 4_CD
        contained_VBD 13_CD patients_NNS who_WP had_VBD no_DT evidence_NN of_IN sepsis_NN ._. The_DT
        mean_JJ age_NN of_IN the_DT patients_NNS was_VBD 50_CD ±_NN 13_CD ._. 6_CD years_NNS ._. Thirty-four_CD
        patients_NNS were_VBD men_NNS ,_, and_CC 21_CD patients_NNS were_VBD women_NNS ._. The_DT overall_JJ
        MAP_NNP was_VBD 72_CD ±_NN 20_CD mmHg_NN at_IN the_DT moment_NN the_DT hemodynamic_JJ values_NNS
        were_VBD chosen_VBN ._. The_DT overall_JJ mean_NN CO_NNP was_VBD 9_CD ._. 2_CD ±_NN 6_CD ._. 18_CD l_NN /_NN min_NN ,_, and_CC
        the_DT mean_NN CI_NNP was_VBD 5_CD ._. 1_CD ±_NN 1_CD ._. 7_CD l_NN /_NN min_NN /_NN m_NN 2_CD ._. The_DT overall_JJ mean_NN SVR_NNP
        was_VBD 435_CD ±_NN 180_CD dynes_NNS ×_NN s_VBZ /_NN cm_NN 5_CD ;_: the_DT mean_NN SVRI_NNP was_VBD 785_CD ±_NN 325_CD
        dynes_NNS ×_NN s_VBZ /_NN cm_NN 5_CD ._. Analysis_NNP of_IN SVRI_NNP was_VBD reviewed_VBN for_IN each_DT
        subgroup_NN and_CC not_RB found_VBD to_TO be_VB different_JJ from_IN the_DT analysis_NN of_IN
        SVR_NNP ;_: therefore_RB ,_, only_RB data_NNS for_IN SVR_NNP are_VBP presented_VBN ._.
        There_EX were_VBD no_DT statistically_RB significant_JJ differences_NNS in_IN
        age_NN ,_, sex_NN ,_, or_CC admission_NN temperature_NN among_IN the_DT different_JJ
        groups_NNS ._. Twenty-two_NNP patients_NNS (_( Groups_NNS 1_CD and_CC 2_LS )_) met_VBD the_DT
        criteria_NNS for_IN the_DT sepsis_NN syndrome_NN [_NN 1_CD ]_NN ._. The_DT mean_NN SVR_NNP was_VBD 445_CD
        ±_NN 168_CD dynes_NNS ×_NN s_VBZ /_NN cm_NN 5_CD ,_, CO_NNP was_VBD 10_CD ._. 86_CD ±_NN 5_CD ._. 22_CD l_NN /_NN min_NN ;_: and_CC CI_NNP was_VBD
        5_CD ._. 08_CD ±_NN 1_CD ._. 64_CD l_NN /_NN min_NN /_NN m_NN 2_CD for_IN this_DT group_NN ._. The_DT overall_JJ mortality_NN
        in_IN those_DT patients_NNS classified_VBN as_IN having_VBG the_DT sepsis_NN syndrome_NN
        was_VBD 50_CD %_NN ._. In_IN patients_NNS with_IN the_DT sepsis_NN syndrome_NN ,_, the_DT lung_NN was_VBD
        the_DT primary_JJ site_NN of_IN infection_NN in_IN 14_CD out_IN of_IN 22_CD patients_NNS ._.
        Thirteen_CD patients_NNS were_VBD considered_VBN nonseptic_JJ (_( Group_NNP 4_LS )_) ._. This_DT
        group_NN had_VBD no_DT source_NN of_IN infection_NN ,_, alteration_NN in_IN
        temperature_NN ,_, leukocytosis_NNS ,_, or_CC leukopenia_NN ._. The_DT mean_JJ
        hemodynamic_JJ values_NNS for_IN this_DT group_NN were_VBD :_: SVR_NNP =_SYM 435_CD ±_NN 180_CD
        dynes_NNS ×_NN s_VBZ /_NN cm_NN 5_CD ;_: CO_NNP =_SYM 9_CD ._. 23_CD ±_NN 4_CD ._. 24_CD l_NN /_NN min_NN ,_, and_CC CI_NNP =_SYM 7_CD ._. 72_CD ±_NN
        1_CD ._. 9_CD l_NN /_NN min_NN /_NN m_NN 2_CD ._. The_DT mortality_NN was_VBD 46_CD %_NN ._. There_EX were_VBD no_DT
        statistically_RB significant_JJ differences_NNS in_IN any_DT hemodynamic_JJ
        values_NNS nor_CC in_IN mortality_NN between_IN the_DT nonseptic_JJ group_NN (_( Group_NNP
        4_LS )_) and_CC the_DT groups_NNS with_IN sepsis_NN syndrome_NN (_( Groups_NNS 1_CD and_CC 2_LS )_) ._.
        The_DT nonseptic_JJ group_NN included_VBD eight_CD patients_NNS with_IN
        intra-abdominal_JJ disease_NN (_( five_CD with_IN decompensated_JJ cirrhosis_NNS ,_,
        three_CD with_IN acute_JJ pancreatitis_NNS )_) ,_, one_CD patient_NN with_IN adrenal_NN
        insufficiency_NN ,_, and_CC four_CD patients_NNS with_IN unclear_JJ etiologies_NNS
        for_IN hypotension_NN and_CC low_JJ SVR_NNP (_( idiopathic_JJ )_) ._. The_DT mortality_NN in_IN
        patients_NNS with_IN decompensated_JJ intra-abdominal_JJ disease_NN was_VBD 75_CD %_NN
        (_( six_CD out_IN of_IN eight_CD )_) ._. Additionally_RB ,_, no_DT statistically_RB
        significant_JJ difference_NN in_IN any_DT of_IN the_DT hemodynamic_JJ values_NNS or_CC
        mortality_NN was_VBD identified_VBN between_IN the_DT four_CD groups_NNS when_WRB
        analyzed_VBD individually_RB (_( Table_NNP 2_LS )_) ._.
        Twenty-seven_NNP patients_NNS met_VBD the_DT criteria_NNS for_IN the_DT extreme_JJ
        hyperdynamic_JJ state_NN (_( EHS_NNP )_) ._. In_IN the_DT literature_NN [_NN 2_CD ]_NN ,_, EHS_NNP is_VBZ
        defined_VBN as_IN an_DT SVR_NNP below_IN 450_CD dynes_NNS ×_NN s_VBZ /_NN cm_NN 5_CD and_CC a_DT CO_NNP above_IN
        7_CD l_NN /_NN min_NN /_NN m_NN 2_CD ._. The_DT mean_JJ hemodynamic_JJ values_NNS for_IN patients_NNS in_IN
        this_DT study_NN with_IN EHS_NNP were_VBD :_: SVR_NNP =_SYM 327_CD ±_NN 85_CD dynes_NNS ×_NN s_VBZ /_NN cm_NN 5_CD ;_: CO_NNP
        =_SYM 12_CD ._. 13_CD ±_NN 3_CD ._. 31_CD l_NN /_NN min_NN ;_: and_CC CI_NNP =_SYM 5_CD ._. 98_CD ±_NN 1_CD ._. 46_CD l_NN /_NN min_NN /_NN m_NN 2_CD ._. Seven_CD
        of_IN these_DT patients_NNS had_VBD a_DT diagnosis_NN of_IN underlying_VBG cirrhosis_NNS ._.
        Twelve_CD of_IN the_DT patients_NNS within_IN this_DT group_NN were_VBD diagnosed_VBN
        with_IN sepsis_NN syndrome_NN ,_, 10_CD with_IN possible_JJ sepsis_NN ,_, and_CC five_CD
        were_VBD nonseptic_JJ ._. This_DT group_NN had_VBD a_DT statistically_RB significant_JJ
        higher_JJR mortality_NN (_( 60_CD %_NN versus_CC 33_CD %_NN )_) than_IN those_DT patient_NN
        without_IN the_DT EHS_NNP (_( 
        P_NN <_NN 0_CD ._. 05_CD )_) ._. A_DT univariant_NN logistic_JJ
        regression_NN was_VBD performed_VBN analyzing_VBG the_DT level_NN of_IN reduction_NN
        of_IN SVR_NNP and_CC mortality_NN ._. A_DT statistically_RB significant_JJ
        relationship_NN was_VBD found_VBN between_IN these_DT variables_NNS (_( 
        P_NN =_SYM 0_CD ._. 025_CD )_) ._. For_IN every_DT reduction_NN in_IN
        SVR_NNP of_IN 50_CD dynes_NNS ×_NN s_VBZ /_NN cm_NN 5_CD ,_, there_EX was_VBD a_DT 20_CD %_NN increase_NN in_IN
        mortality_NN (_( odds_NNS ratio_NN =_SYM 1_CD ._. 2_CD ;_: range_NN =_SYM 1_CD ._. 022_CD -_: 1_CD ._. 434_CD )_) ._.
      
      
        Discussion_NNP
        Sepsis_NNP and_CC sepsis_NN syndrome_NN were_VBD the_DT most_RBS common_JJ
        etiologies_NNS of_IN a_DT low_JJ SVR_NNP in_IN this_DT study_NN ._. Although_IN many_JJ
        studies_NNS have_VBP found_VBN urinary_JJ or_CC intra-abdominal_JJ sepsis_NN to_TO be_VB
        the_DT most_RBS common_JJ cause_NN of_IN low_JJ SVR_NNP [_NN 3_CD ]_NN ,_, the_DT lung_NN was_VBD the_DT
        primary_JJ site_NN of_IN infection_NN in_IN over_IN half_NN of_IN our_PRP$ patients_NNS ._.
        Septic_NNP shock_NN ,_, the_DT leading_VBG cause_NN of_IN intensive_JJ care_NN unit_NN
        mortality_NN ,_, is_VBZ caused_VBN by_IN systemic_JJ activation_NN of_IN the_DT
        inflammatory_JJ cascade_NN ._. Numerous_JJ mediators_NNS ,_, including_VBG
        cytokines_NNS ,_, kinins_NNS ,_, complement_VB ,_, coagulation_NN factors_NNS ,_, and_CC
        eicosanoids_NNS ,_, are_VBP activated_VBN or_CC systematically_RB released_VBN ,_,
        resulting_VBG in_IN profound_JJ disturbances_NNS of_IN cardiovascular_JJ and_CC
        organ_NN system_NN function_NN ._. These_DT mediators_NNS ,_, particularly_RB tumor_NN
        necrosis_NNS factor_NN (_( TNF_NNP )_) ,_, interleukin_NN (_( IL_NNP )_) -_: 1_CD ,_, platelet_NN
        activating_VBG factor_NN ,_, and_CC prostaglandins_NNS ,_, are_VBP thought_VBN to_TO
        mediate_VB the_DT reduced_VBN peripheral_JJ vascular_NN resistance_NN seen_VBN in_IN
        septic_JJ shock_NN [_NN 4_CD ,_, 5_CD ,_, 6_CD ]_NN ._.
        Parker_NNP 
        et_CC al_NN [_NN 7_CD ]_NN studied_VBD serial_NN
        cardiovascular_JJ variables_NNS in_IN humans_NNS with_IN septic_JJ shock_NN ._. A_DT low_JJ
        SVR_NNP was_VBD seen_VBN in_IN both_DT survivors_NNS and_CC nonsurvivors_NNS ;_: however_RB ,_,
        persistently_RB low_JJ SVR_NNP beyond_IN 24_CD h_NN was_VBD a_DT strong_JJ predictor_NN of_IN
        mortality_NN ._. This_DT study_NN demonstrated_VBN that_IN the_DT majority_NN of_IN
        patients_NNS (_( 65_CD %_NN )_) who_WP die_NN of_IN septic_JJ shock_NN have_VBP a_DT persistently_RB
        low_JJ SVR_NNP ,_, while_IN a_DT smaller_JJR percentage_NN die_NN of_IN low_JJ CO_NNP (_( 10_CD %_NN )_) or_CC
        of_IN multiple_JJ organ_NN failure_NN (_( 25_CD %_NN )_) after_IN hemodynamic_JJ
        resolution_NN of_IN shock_NN ._. Although_IN we_PRP did_VBD not_RB evaluate_VB serial_NN
        hemodynamic_JJ profiles_NNS in_IN this_DT study_NN ,_, our_PRP$ data_NNS identify_VBP a_DT
        group_NN of_IN patients_NNS with_IN EHS_NNP who_WP demonstrate_VBP a_DT SVR_NNP below_IN 450_CD
        dynes_NNS ×_NN s_VBZ /_NN cm_NN 5_CD and_CC a_DT mean_NN CO_NNP over_IN 12_CD l_NN /_NN min_NN ._. As_IN with_IN patients_NNS
        in_IN prior_JJ studies_VBZ [_NN 2_CD ]_NN ,_, this_DT group_NN demonstrated_VBD a_DT
        significantly_RB higher_JJR mortality_NN ._. Although_IN the_DT mechanisms_NNS
        relating_VBG to_TO the_DT difference_NN in_IN mortality_NN are_VBP unknown_JJ ,_, it_PRP has_VBZ
        been_VBN suggested_VBN that_IN patients_NNS with_IN "_'' complicated_VBN "_'' shock_NN
        (_( defined_VBN as_IN multiorgan_NN failure_NN )_) have_VBP greater_JJR distortions_NNS of_IN
        cardiorespiratory_NN patterns_NNS relative_JJ to_TO the_DT degree_NN of_IN
        hypotension_NN and_CC that_IN this_DT is_VBZ associated_VBN with_IN a_DT higher_JJR
        mortality_NN [_NN 8_CD ,_, 9_CD ]_NN
        Our_PRP$ study_NN demonstrates_VBZ that_IN patients_NNS with_IN sepsis_NN
        syndrome_NN are_VBP the_DT most_RBS common_JJ group_NN of_IN patients_NNS presenting_VBG
        with_IN hypotension_NN and_CC a_DT low_JJ SVR_NNP in_IN the_DT medical_JJ intensive_JJ
        care_NN unit_NN ._. This_DT group_NN only_RB represents_VBZ approximately_RB 40_CD %_NN of_IN
        patients_NNS in_IN our_PRP$ study_NN ._. While_IN many_JJ of_IN the_DT remaining_VBG patients_NNS
        had_VBD some_DT evidence_NN supporting_VBG the_DT diagnosis_NN of_IN sepsis_NN (_( eg_NN
        fever_NN ,_, leukocytosis_NNS )_) ,_, they_PRP lacked_VBD an_DT identifiable_JJ source_NN of_IN
        infection_NN ,_, and_CC the_DT exact_JJ etiology_NN of_IN their_PRP$ hypotension_NN
        remains_VBZ unknown_JJ ._. More_RBR significantly_RB ,_, almost_RB one-quarter_NN of_IN
        the_DT patients_NNS (_( 24_CD %_NN )_) in_IN this_DT study_NN developed_VBD hypotension_NN and_CC
        a_DT low_JJ SVR_NNP without_IN any_DT evidence_NN of_IN sepsis_NN ._. This_DT group_NN had_VBD a_DT
        high_JJ mortality_NN (_( 46_CD %_NN )_) ,_, similar_JJ to_TO the_DT remaining_VBG patients_NNS
        (_( 54_CD %_NN )_) ._. There_EX were_VBD no_DT significant_JJ differences_NNS in_IN the_DT
        clinical_JJ or_CC hemodynamic_JJ parameters_NNS between_IN the_DT nonseptic_JJ
        patients_NNS and_CC the_DT patients_NNS in_IN the_DT remaining_VBG groups_NNS ._. The_DT
        frequency_NN of_IN nonseptic_JJ causes_NNS of_IN a_DT low_JJ SVR_NNP suggest_VBP that_IN
        clinicians_NNS must_MD be_VB aware_JJ of_IN conditions_NNS other_JJ than_IN sepsis_NN
        that_WDT have_VBP either_DT been_VBN well_RB documented_VBN (_( Table_NNP 3_LS )_) or_CC reported_VBD
        to_TO induce_VB a_DT reduction_NN in_IN the_DT SVR_NNP (_( Table_NNP 4_LS )_) ._.
        The_DT largest_JJS group_NN of_IN nonseptic_JJ patients_NNS in_IN this_DT study_NN
        with_IN hypotension_NN and_CC a_DT low_JJ SVR_NNP was_VBD found_VBN to_TO be_VB patients_NNS
        with_IN decompensated_JJ cirrhosis_NNS ._. Although_IN occult_NN infections_NNS
        should_MD not_RB be_VB excluded_VBN ,_, none_NN of_IN these_DT patients_NNS had_VBD fever_NN ,_,
        leukocytosis_NNS ,_, an_DT identifiable_JJ site_NN of_IN infection_NN ,_, or_CC
        abnormalities_NNS in_IN the_DT peritoneal_JJ fluid_NN ._. Patients_NNS with_IN liver_NN
        cirrhosis_NNS often_RB present_VBP with_IN systemic_JJ hemodynamic_JJ
        disturbances_NNS ,_, including_VBG hypotension_NN ,_, low_JJ SVR_NNP ,_, and_CC a_DT reduced_VBN
        sensitivity_NN to_TO vasoconstrictors_NNS [_NN 10_CD ]_NN ._. The_DT precise_JJ
        mechanisms_NNS of_IN these_DT hemodynamic_JJ disorders_NNS have_VBP not_RB yet_RB been_VBN
        clearly_RB elucidated_JJ ._. Excessive_NNP production_NN of_IN vasodilators_NNS ,_,
        peripheral_JJ shunts_NNS ,_, and_CC increased_VBN levels_NNS of_IN nitric_JJ oxide_NN in_IN
        these_DT patients_NNS may_MD contribute_VB to_TO the_DT hyperdynamic_JJ state_NN
        observed_VBD in_IN this_DT population_NN [_NN 10_CD ,_, 11_CD ,_, 12_CD ,_, 13_CD ,_, 14_CD ,_, 15_CD ,_, 16_CD ]_NN ._.
        A_DT recent_JJ study_NN by_IN Matsumoto_NNP [_NN 16_CD ]_NN demonstrated_VBN that_IN
        patients_NNS with_IN decompensated_JJ liver_NN cirrhosis_NNS had_VBD higher_JJR
        levels_NNS of_IN exhaled_VBD nitric_JJ oxide_NN than_IN patients_NNS with_IN
        compensated_VBN cirrhosis_NNS ,_, chronic_JJ liver_NN disease_NN ,_, or_CC controls_NNS ._.
        The_DT decompensated_JJ cirrhotics_NNS had_VBD a_DT significantly_RB higher_JJR CO_NNP
        and_CC a_DT lower_JJR SVR_NNP than_IN the_DT compensated_VBN patients_NNS ._.
        Additionally_RB ,_, a_DT positive_JJ correlation_NN was_VBD found_VBN between_IN the_DT
        level_NN of_IN nitric_JJ oxide_NN and_CC CI_NNP ._. Five_CD of_IN our_PRP$ patients_NNS with_IN a_DT
        low_JJ SVR_NNP had_VBD decompensated_JJ liver_NN disease_NN as_IN the_DT presumed_VBN
        etiology_NN of_IN their_PRP$ hypotension_NN ._. Another_DT five_CD patients_NNS in_IN the_DT
        possible_JJ sepsis_NN group_NN had_VBD hypotension_NN with_IN a_DT clinical_JJ
        diagnosis_NN of_IN spontaneous_JJ bacterial_JJ peritonitis_NNS ;_: however_RB ,_,
        the_DT lack_NN of_IN positive_JJ cultures_NNS ,_, or_CC any_DT other_JJ evidence_NN of_IN
        infection_NN ,_, suggest_VBP that_IN decompensated_JJ liver_NN disease_NN may_MD
        have_VB played_VBN a_DT significant_JJ role_NN in_IN their_PRP$ hypotension_NN ._.
        Pancreatitis_NNP was_VBD found_VBN to_TO be_VB the_DT second_JJ most_RBS common_JJ
        cause_NN of_IN low_JJ SVR_NNP in_IN patients_NNS without_IN evidence_NN of_IN infection_NN ._.
        Three_CD patients_NNS had_VBD necrotizing_VBG pancreatitis_NNS ,_, with_IN one_CD of_IN
        these_DT having_VBG evidence_NN of_IN hemorrhage_NN into_IN the_DT pancreas_NN ._.
        Hemodynamic_NNP manifestations_NNS of_IN pancreatitis_NNS include_VBP a_DT
        normodynamic_JJ or_CC hypodynamic_JJ state_NN ,_, usually_RB present_JJ in_IN acute_JJ
        interstitial_NN pancreatitis_NNS and_CC commonly_RB associated_VBN with_IN
        hypovolemia_NN ._. Pancreatitis_NNP can_MD also_RB present_VB as_IN a_DT
        hyperdynamic_JJ state_NN with_IN high_JJ CO_NNP and_CC a_DT low_JJ SVR_NNP as_IN described_VBN
        by_IN Di_NNP Carlo_NNP 
        et_CC al_NN [_NN 17_CD ]_NN and_CC Bradley_NNP 
        et_CC al_NN [_NN 18_CD ]_NN ._. This_DT hyperdynamic_JJ state_NN
        is_VBZ another_DT manifestation_NN of_IN the_DT severity_NN of_IN acute_JJ
        pancreatitis_NNS and_CC is_VBZ seen_VBN mostly_RB in_IN necrotizing_VBG pancreatitis_NNS
        with_IN or_CC without_IN hemorrhage_NN [_NN 19_CD ]_NN ._. Severe_NNP pancreatitis_NNS may_MD
        mimic_VB sepsis_NN syndrome_NN or_CC septic_JJ shock_NN despite_IN the_DT absence_NN
        of_IN any_DT infectious_JJ site_NN ._. The_DT mechanisms_NNS responsible_JJ for_IN
        pancreatic_JJ shock_NN have_VBP not_RB been_VBN elucidated_JJ ;_: however_RB ,_, an_DT
        inflammatory_JJ cascade_NN generalized_JJ by_IN cytokines_NNS and_CC TNF_NNP is_VBZ
        felt_VBN to_TO be_VB the_DT most_RBS likely_JJ cause_NN of_IN this_DT process_NN [_NN 17_CD ,_, 18_CD ,_,
        19_CD ]_NN ._.
        Adrenal_NNP insufficiency_NN was_VBD found_VBN in_IN one_CD of_IN our_PRP$ patients_NNS
        with_IN no_DT evidence_NN of_IN infection_NN ._. Unfortunately_RB ,_, cortisol_NN
        levels_NNS and_CC adrenocorticotrophic_JJ hormone_NN (_( ACTH_NNP )_) response_NN was_VBD
        not_RB routinely_RB measured_VBN in_IN patients_NNS with_IN infection_NN ,_, and_CC
        adrenal_NN insufficiency_NN may_MD have_VB been_VBN underestimated_VBN in_IN this_DT
        group_NN ._. Adrenal_NNP insufficiency_NN may_MD present_VB as_IN a_DT hypodynamic_JJ ,_,
        normodynamic_JJ ,_, or_CC hyperdynamic_JJ state_NN [_NN 20_CD ]_NN ._. The_DT hypodynamic_JJ
        state_NN is_VBZ usually_RB seen_VBN early_RB in_IN adrenal_NN insufficiency_NN and_CC is_VBZ
        associated_VBN with_IN volume_NN depletion_NN from_IN diarrhea_NN ,_, vomiting_NN ,_,
        and_CC decreased_VBD reabsorption_NN of_IN sodium_NN in_IN the_DT distal_NN tubule_NN ._.
        CO_NNP may_MD also_RB be_VB decreased_VBN in_IN adrenal_NN insufficiency_NN as_IN the_DT
        result_NN of_IN the_DT myofibrillar_NN adenosine_NN triphosphate_NN (_( ATP_NNP )_)
        depletion_NN seen_VBN with_IN glucocorticoid_NN deficiency_NN [_NN 20_CD ]_NN ._.
        Intravenous_NNP fluid_JJ therapy_NN most_RBS often_RB increases_VBZ CO_NNP and_CC
        decreases_NNS SVR_NNP in_IN patients_NNS with_IN adrenal_NN crisis_NN ._. These_DT
        patients_NNS are_VBP usually_RB separated_JJ from_IN patients_NNS with_IN sepsis_NN by_IN
        a_DT baseline_NN cortisol_NN level_NN below_IN 10_CD μ_NN g_SYM /_NN dl_NN or_CC an_DT inadequate_JJ
        response_NN to_TO ACTH_NNP [_NN 20_CD ]_NN ._. One_CD of_IN our_PRP$ patients_NNS with_IN septic_JJ
        shock_NN had_VBD baseline_NN cortisol_NN of_IN 22_CD μ_NN g_SYM /_NN dl_NN and_CC no_DT response_NN to_TO
        the_DT cosyntropin_NN stimulation_NN test_NN ._. This_DT patient_NN could_MD not_RB be_VB
        weaned_JJ off_IN high_JJ dose_NN norepinephrine_NN and_CC dopamine_NN until_IN
        intravenous_JJ corticosteroids_NNS were_VBD instituted_VBN ._. Normal_NNP values_NNS
        for_IN basal_NN and_CC stimulated_VBN cortisol_NN levels_NNS are_VBP derived_VBN from_IN
        the_DT adrenal_NN response_NN of_IN healthy_JJ individuals_NNS ._. Patients_NNS
        experiencing_VBG the_DT severe_JJ stress_NN of_IN critical_JJ illness_NN
        demonstrate_VB higher_JJR than_IN normal_JJ amounts_NNS of_IN circulating_VBG
        cortisol_NN ._. Some_DT patients_NNS with_IN critical_JJ illness_NN have_VBP minimal_JJ
        or_CC no_DT ACTH_NNP stimulation_NN above_IN their_PRP$ baseline_NN cortisol_NN levels_NNS
        and_CC may_MD be_VB unable_JJ to_TO respond_VB to_TO additional_JJ physiologic_JJ
        stress_NN [_NN 20_CD ]_NN ._. Several_JJ reports_NNS suggest_VBP a_DT significant_JJ number_NN
        of_IN critically_RB ill_JJ patients_NNS may_MD have_VB unrecognized_JJ adrenal_NN
        insufficiency_NN [_NN 21_CD ,_, 22_CD ,_, 23_CD ,_, 24_CD ]_NN ._.
        Four_CD cases_NNS of_IN idiopathic_JJ hypotension_NN with_IN low_JJ SVR_NNP were_VBD
        identified_VBN in_IN our_PRP$ patients_NNS ._. One_CD case_NN was_VBD felt_VBN to_TO be_VB related_VBN
        to_TO possible_JJ anaphylaxis_NNS or_CC anaphylactoid_NN reaction_NN but_CC was_VBD
        not_RB well_RB documented_VBN ._. Silverman_NNP 
        et_CC al_NN [_NN 25_CD ]_NN reported_VBD a_DT patient_NN who_WP
        developed_VBD anaphylactic_JJ shock_NN secondary_JJ to_TO penicillin_NN 7_CD days_NNS
        postmyocardial_NN infarction_NN ;_: the_DT hemodynamic_JJ parameters_NNS
        showed_VBD a_DT decrease_NN in_IN CO_NNP and_CC MAP_NNP with_IN an_DT increase_NN in_IN SVR_NNP ._.
        Moss_NNP 
        et_CC al_NN [_NN 26_CD ]_NN reported_VBD the_DT opposite_JJ
        hemodynamic_JJ profile_NN in_IN a_DT patient_NN with_IN anaphylactic_JJ shock_NN
        secondary_JJ to_TO succinycholine_NN ._. Their_PRP$ patient_NN developed_VBD a_DT low_JJ
        SVR_NNP and_CC a_DT high_JJ CO_NNP which_WDT correlated_JJ with_IN increased_VBN levels_NNS of_IN
        histamine_NN and_CC catecholamines_NNS ._. Although_IN there_EX are_VBP minimal_JJ
        human_JJ data_NNS ,_, animal_NN studies_NNS suggest_VBP there_EX is_VBZ an_DT initial_JJ
        hypodynamic_JJ state_NN secondary_JJ to_TO severe_JJ extravasation_NN of_IN
        fluids_NNS into_IN the_DT tissues_NNS followed_VBN by_IN a_DT hyperdynamic_JJ state_NN
        after_IN fluid_JJ resuscitation_NN ._.
        Our_PRP$ second_JJ case_NN of_IN hypotension_NN with_IN a_DT low_JJ SVR_NNP presented_VBD
        in_IN the_DT setting_NN of_IN an_DT acute_JJ myocardial_NN infarction_NN ._. Although_IN
        cardiogenic_JJ shock_NN presents_VBZ with_IN a_DT high_JJ SVR_NNP and_CC low_JJ CO_NNP ,_, some_DT
        data_NNS suggest_VBP that_IN ,_, rarely_RB ,_, patients_NNS may_MD present_VB with_IN a_DT
        syndrome_NN of_IN low_JJ SVR_NNP ._. McCriskin_NNP 
        et_CC al_NN [_NN 27_CD ]_NN reported_VBD a_DT patient_NN with_IN a_DT
        left_VBN ventricular_NN pseudoaneurysm_NN postmyocardial_NN infarct_NN with_IN
        a_DT low_JJ SVR_NNP and_CC no_DT evidence_NN of_IN infection_NN ._. Costantin_NNP [_NN 28_CD ]_NN
        developed_VBD an_DT animal_NN model_NN in_IN dogs_NNS and_CC demonstrated_VBD a_DT subset_NN
        of_IN animals_NNS with_IN a_DT hyperdynamic_JJ state_NN after_IN coronary_JJ
        occlusion_NN ;_: however_RB ,_, Ross_NNP 
        et_CC al_NN [_NN 29_CD ]_NN were_VBD unable_JJ to_TO confirm_VB
        these_DT results_NNS using_VBG another_DT animal_NN model_NN ._. Similarly_RB ,_, Smith_NNP 
        et_CC al_NN [_NN 30_CD ]_NN ,_, in_IN one_CD of_IN the_DT original_JJ
        hemodynamic_JJ descriptions_NNS of_IN patients_NNS after_IN myocardial_NN
        infarction_NN ,_, did_VBD not_RB identify_VB any_DT patient_NN with_IN a_DT
        hyperdynamic_JJ state_NN ._. Another_DT recently_RB described_VBN cause_NN of_IN low_JJ
        SVR_NNP in_IN cardiac_JJ patients_NNS is_VBZ the_DT "_'' vasoplegic_JJ syndrome_NN "_'' ._. This_DT
        syndrome_NN occurs_VBZ within_IN 6_CD h_NN after_IN cardiac_JJ surgery_NN using_VBG
        extracorporeal_NN circulation_NN [_NN 31_CD ]_NN ._. The_DT incidence_NN has_VBZ been_VBN
        estimated_VBN between_IN 0_CD ._. 4_CD and_CC 5_CD %_NN of_IN patients_NNS undergoing_VBG
        cardiovascular_JJ surgery_NN using_VBG cardiopulmonary_JJ bypass_NN [_NN 31_CD ,_,
        32_CD ]_NN ._. The_DT etiology_NN is_VBZ unclear_JJ but_CC has_VBZ not_RB been_VBN associated_VBN
        with_IN increased_VBN levels_NNS of_IN nitric_JJ oxide_NN or_CC endotoxin_NN ._.
        One_CD patient_NN with_IN a_DT low_JJ SVR_NNP classified_VBD as_IN idiopathic_JJ had_VBD
        a_DT history_NN of_IN significant_JJ alcohol_NN consumption_NN ._. Their_PRP$ initial_JJ
        hemodynamic_JJ parameters_NNS showed_VBD a_DT low_JJ SVR_NNP with_IN high_JJ CO_NNP which_WDT
        rapidly_RB resolved_VBN after_IN intravenous_JJ thiamine_NN and_CC
        broad-spectrum_JJ antibiotics_NNS ._. It_PRP is_VBZ possible_JJ that_IN this_DT case_NN
        represents_VBZ a_DT variant_NN of_IN beriberi_NN heart_NN disease_NN ._. This_DT rare_JJ
        but_CC treatable_JJ disease_NN should_MD be_VB considered_VBN in_IN every_DT patient_NN
        with_IN congestive_JJ heart_NN failure_NN and_CC a_DT low_JJ SVR_NNP ._. The_DT fulminant_NN
        form_NN known_VBN as_IN Shosin_NNP beriberi_NN presents_VBZ as_IN a_DT high_JJ CO_NNP state_NN
        with_IN extremely_RB high_JJ CO_NNP and_CC a_DT low_JJ SVR_NNP which_WDT rapidly_RB responds_VBZ
        to_TO thiamine_NN [_NN 33_CD ,_, 34_CD ,_, 35_CD ]_NN ._.
        The_DT remaining_VBG patient_NN in_IN the_DT idiopathic_JJ group_NN had_VBD no_DT
        explanation_NN for_IN their_PRP$ low_JJ SVR_NNP syndrome_NN ._. Review_NNP of_IN the_DT
        literature_NN shows_VBZ many_JJ causes_NNS of_IN a_DT low_JJ SVR_NNP (_( Tables_NNP 3_CD and_CC 4_LS )_) ,_,
        and_CC it_PRP is_VBZ possible_JJ that_IN one_CD of_IN these_DT diagnosis_NN was_VBD missed_VBN
        by_IN the_DT clinicians_NNS caring_VBG for_IN this_DT patient_NN ._. The_DT patient_NN had_VBD
        normal_JJ urine_NN drug_NN abuse_NN screens_NNS and_CC a_DT normal_JJ serum_NN
        acetaminophen_NN level_NN ._. A_DT salicylate_NN level_NN was_VBD not_RB obtained_VBN ._.
        Leatherman_NNP and_CC Schmitz_NNP [_NN 36_CD ]_NN reported_VBD a_DT series_NN of_IN five_CD
        patients_NNS who_WP became_VBD accidentally_RB intoxicated_JJ with_IN
        salicylates_NNS with_IN clinical_JJ ,_, laboratory_NN ,_, and_CC hemodynamic_JJ
        features_NNS of_IN sepsis_NN ,_, but_CC without_IN bacteriological_JJ evidence_NN ._.
        In_IN two_CD of_IN the_DT cases_NNS ,_, TNF-α_NNP ,_, IL-_NNP 1_CD and_CC IL-_NNP 6_CD were_VBD measured_VBN and_CC
        found_VBN to_TO be_VB significantly_RB elevated_VBD ._. Other_JJ drugs_NNS have_VBP been_VBN
        associated_VBN with_IN a_DT low_JJ SVR_NNP including_VBG tricyclic_JJ
        antidepressants_NNS ,_, anesthetic_JJ agents_NNS ,_, and_CC narcotics_NNS ._. Recently_RB
        Nguyen_NNP 
        et_CC al_NN [_NN 37_CD ]_NN reported_VBD hyperdynamic_JJ
        shock_NN caused_VBN by_IN trimethoprim-sulfamethoxazole_JJ in_IN which_WDT
        immunoglobulin_NN E_NNP antibodies_NNS and_CC TNF_NNP were_VBD not_RB detected_VBN and_CC
        complement_VB levels_NNS were_VBD normal_JJ ,_, suggesting_VBG a_DT mechanism_NN other_JJ
        than_IN anaphylaxis_NNS ._. Our_PRP$ drug_NN screen_NN should_MD have_VB identified_VBN
        tricyclic_JJ antidepressants_NNS or_CC narcotics_NNS in_IN the_DT urine_NN ;_:
        however_RB ,_, a_DT careful_JJ drug_NN history_NN was_VBD not_RB elicited_JJ in_IN this_DT
        patient_NN ._. Although_IN other_JJ conditions_NNS such_JJ as_IN head_NN injury_NN [_NN
        38_CD ,_, 39_CD ,_, 40_CD ]_NN ,_, Paget_NNP 's_POS disease_NN [_NN 41_CD ,_, 42_CD ,_, 43_CD ]_NN ,_, arteriovenous_JJ
        fistula_NN [_NN 44_CD ]_NN ,_, severe_JJ anemia_NN [_NN 45_CD ,_, 46_CD ]_NN ,_, multiple_JJ myeloma_NN [_NN
        47_CD ]_NN ,_, thyrotoxicosis_NNS [_NN 48_CD ]_NN ,_, and_CC spinal_JJ cord_NN injury_NN [_NN 49_CD ]_NN
        have_VBP been_VBN reported_VBN to_TO produce_VB a_DT low_JJ SVR_NNP ,_, this_DT patient_NN
        lacked_VBD any_DT clinical_JJ evidence_NN suggesting_VBG one_CD of_IN these_DT
        diagnoses_NNS ;_: his_PRP$ hypotension_NN resolved_VBN spontaneously_RB ._.
      
      
        Conclusion_NNP
        In_IN summary_NN ,_, we_PRP describe_VBP a_DT group_NN of_IN 55_CD patients_NNS with_IN a_DT
        SVR_NNP below_IN 800_CD dynes_NNS ×_NN s_VBZ /_NN cm_NN 5_CD ,_, and_CC a_DT subgroup_NN of_IN 13_CD non-septic_JJ
        patents_NNS (_( 24_CD %_NN )_) with_IN a_DT similar_JJ mortality_NN ._. This_DT study_NN
        emphasizes_VBZ the_DT importance_NN of_IN considering_VBG other_JJ conditions_NNS
        besides_IN sepsis_NN in_IN patients_NNS presenting_VBG with_IN hypotension_NN and_CC
        a_DT low_JJ SVR_NNP ._.
      
    
  
